AI model targets inflammation, helping cardiologists find ‘invisible’ heart patients

Professor Keith Channon, Co-founder & Chief Medical Officer, Caristo Diagnostics, shares results from the ORFAN study unveiled at American Heart Association (AHA)’s Late-Breaking Science Session with leading healthcare media outlet, Cardiovascular Business. Watch his interview here.